FindTrial
Sign In

A randomized controlled trial of intranasal dexmedetomidine plus buccal midazolam vs intranasal dexmedetomidine plus Intravenous propofol for enhanced CT testing in children enhanced computerised tomographic (CT)

A randomized controlled trial of intranasal dexmedetomidine plus buccal midazolam vs intranasal dexmedetomidine plus Intravenous propofol for enhanced CT testing in children enhanced computerised tomographic (CT)

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067469
Enrollment
Unknown
Registered
2023-01-09
Start date
2023-02-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

various diseases

Interventions

group DM:Sedation was performed with buccal midazolam to intranasal dexmedetomidine
group DB:Sedation was performed with low-dose propofol with intranasal dexmedetomidine

Sponsors

Fujian Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 6 Years

Inclusion criteria

Inclusion criteria: Children with ASA physical status I or II, aged between 6 months and 6 years, scheduled for enhanced CT test under sedation at our center

Exclusion criteria

Exclusion criteria: history of significant active cardiac, pulmonary, hepatic, or renal disease;history of diagnosed obstructive sleep apnea;or history of allergy or sensitivity to study drugs

Design outcomes

Primary

MeasureTime frame
success rate of sedation;—

Secondary

MeasureTime frame
recovery time;—

Countries

China

Contacts

Public ContactSujing-Zhang

Fujian Children's Hospital

zhsj869303@163.com15880003654

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026